TP53 and breast cancer: The lifetime risk of breast cancer in TP53 mutation carriers is up to 80–90%, which is even higher than those harboring a BRCA1 or BRCA2 (BRCA) mutation: the most commonly identified high penetrance germline gene mutations in hereditary breast cancer [3].